Top-Analysts PicksInvest alongside the top 15% of Wall Street analysts.

Try Top-Picks
Voyager Therapeutics, Inc. Banner

Voyager Therapeutics, Inc.

VYGR Stock Analysis

Page title

Section title

Breakdown
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Net Income
-16.317m-29.672m-40.193m-70.698m-88.288m-43.597m36.741M-71.197m-46.408m132.330M
Depreciation & Amortization
184.000K600.000K612.000K1.595M2.117M2.765M3.817M5.165M6.191M4.441M
Change in Working Capital
477.000K56.142M-12.848m-2.135m55.381M78.438M-144.537m3.294M20.471M-66.557m
Operating Cash Flow
-11.918m41.299M-42.482m-61.350m-15.887m48.666M-96.716m-53.525m-12.509m77.919M
Capital Expenditure
-2.988m-1.030m-5.029m-3.985m-4.305m-7.718m-12.097m-1.609m-2.491m-3.256m
Free Cash Flow
-14.906m40.269M-47.511m-65.335m-20.192m40.948M-108.813m-55.134m-15.000m74.663M
Debt Repayment
0.0000.0000.0000.0000.0000.0000.0000.0000.0000.000
Dividends Paid
0.0000.0000.0000.0000.0000.0000.0000.0000.0000.000
Common Stock Issued
80.000K104.779M514.000K57.994M4.749M77.617M3.163M612.000K1.110M31.121M
Common Stock Repurchased
0.0000.0000.0000.000860.000K0.000844.000K584.000K481.000K0.000
Net Change in Cash
6.900M24.274M5.332M-5.111m15.329M39.183M19.442M12.993M-18.738m-30.079m